Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports ; volume:19 ; number:1 ; day:29 ; month:11 ; year:2019 ; pages:1-6 ; date:12.2019
BMC urology ; 19, Heft 1 (29.11.2019), 1-6, 12.2019
- Creator
-
Minnee, Pieter
Hessels, Daphne
Schalken, Jack A.
Van Criekinge, Wim
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12894-019-0561-6
- URN
-
urn:nbn:de:101:1-2020032423104143924460
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Minnee, Pieter
- Hessels, Daphne
- Schalken, Jack A.
- Van Criekinge, Wim
- SpringerLink (Online service)
Other Objects (12)
Clinically significant differences: what to choose?
Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
Metabolomics of clinically significant mTOR dysregulations
Radiological semantics discriminate clinically significant grade prostate cancer
Non-invasive Assessment of Clinically Significant Portal Hypertension
Plasma cyclic guanosine monophosphate is a promising biomarker of clinically significant portal hypertension in patients with liver cirrhosis
Managing clinically significant findings in research: The UK10K example
Determinants of sexual dysfunction among clinically diagnosed diabetic patients
Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer’s disease GWAS and self-report proxy phenotype GWAX
Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically
Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker
Applications of urinary proteomics in biomarker discovery
Clinically significant differences: what to choose?
Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
Metabolomics of clinically significant mTOR dysregulations
Radiological semantics discriminate clinically significant grade prostate cancer
Non-invasive Assessment of Clinically Significant Portal Hypertension
Plasma cyclic guanosine monophosphate is a promising biomarker of clinically significant portal hypertension in patients with liver cirrhosis
Managing clinically significant findings in research: The UK10K example
Determinants of sexual dysfunction among clinically diagnosed diabetic patients
Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer’s disease GWAS and self-report proxy phenotype GWAX
Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically
Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker
Applications of urinary proteomics in biomarker discovery
Clinically significant differences: what to choose?
Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
Metabolomics of clinically significant mTOR dysregulations
Radiological semantics discriminate clinically significant grade prostate cancer
Non-invasive Assessment of Clinically Significant Portal Hypertension
Plasma cyclic guanosine monophosphate is a promising biomarker of clinically significant portal hypertension in patients with liver cirrhosis
Managing clinically significant findings in research: The UK10K example
Determinants of sexual dysfunction among clinically diagnosed diabetic patients
Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer’s disease GWAS and self-report proxy phenotype GWAX
Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically
Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker